QuantLogix ← IVZ scorecard
📅 IVZ Earnings Preview
Invesco LTD
Next report (est.)
September 20, 2026
Countdown
99 days
EPS growth YoY
+34.2%
Revenue growth YoY
+14.1%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
May 5, 2026 ±3.7% +3.0% over-priced
November 4, 2025 ±3.1% -1.4% over-priced
August 1, 2025 ±2.5% -1.9% over-priced
April 28, 2025 ±5.5% +0.1% over-priced
October 29, 2024 ±2.8% +0.2% over-priced
July 31, 2024 ±2.9% +0.2% over-priced
May 1, 2024 ±2.6% +1.2% over-priced
October 31, 2023 ±3.9% +0.1% over-priced
Across these reports, options implied an average ±3.4% move vs an actual average of 1.0% — the stock stayed inside the implied band 100% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q1 FY2026 $0.51 $1.7B $219M
Q4 FY2025 $-2.61 $1.7B $-996M
Q3 FY2025 $0.66 $1.6B $356M
Q2 FY2025 $-0.03 $1.5B $197M
Analyst posture
Buy / Strong Buy
8
Hold
9
Sell
0
Stable: +0 net change 30d
Live 5-factor engine read: Buy · 65/100 Full scorecard →
Get alerted before every IVZ report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on IVZ before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Invesco LTD (IVZ) reports in 99 days, with the next report estimated for September 20, 2026. Across the last 8 reports, options priced an average ±3.4% earnings move while the stock actually moved 1.0% on average — the market has systematically over-priced IVZ's earnings risk. Fundamentals into the print: EPS up 34.2% year-over-year, revenue up 14.1%. QuantLogix's live 5-factor engine currently reads IVZ as a buy at 65/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →